Voltaren 75mg/3ml ampoules
Indication
Voltaren® 75mg/3ml ampoules contain the sodium salt of diclofenac, a non-steroidal agent known for its pronounced antirheumatic, anti-inflammatory, analgesic, and antipyretic activity.¹
Dosage
Image
| The dose is generally one 75 mg ampoule daily.1 |
Image
| In severe cases (e.g., colic),the daily dose canexceptionally be increased to two 75 mgampoules, separated by an interval of a fewhours (one into each buttock}.1 |
Efficacy
In clinical trials, the product has also been shown to exert a pronounced analgesic effect in moderate and severe pain of non-rheumatic origin. This effect sets in within 15-30 minutes.1
Pharmacokinetics
Voltaren®: Mean peak plasma concentrations are reached.1
Peak plasma concentrations are reached after about 20 minutes.1
Time required by Voltaren® to reach mean peak plasma concertation1
For Voltaren® 75mg Abbreviated prescribing information
For Voltaren® 75mg Abbreviated prescribing information
References
Voltaren® ampoules Egyptian drug authority leaflet approval date. Approved on 10/02/2025
Approved by Egyptian Drug Authority: HF0082OA4734/092025. Invalidation date: 01/09/2027.
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg
Image
|
HF0082OA4734/092025 |
Adverse Events Reporting We encourage using the following Electronic reporting tool for reporting into the safety database directly: |